HGH vs Peptides Which is Better for Anti-Aging
For about two years now, I've noticed something interesting. People over 50 don't seem to respond as well to growth hormone peptides as younger folks do. Jay and I have talked about this a lot. Why does someone in their 60s get a massive response from bioidentical HGH while peptides barely move the needle?
This article is my best thinking on that question. It's not hard science. It's my anecdotal experience from coaching thousands of people, plus some digging into the mechanisms.
What I've Actually Seen
People in their 30s and 40s get great results from peptides like Ipamorelin and Tesamorelin. Often as good as bioidentical HGH itself.
But after 50, the pattern shifts. Someone who's 65 will tell me HGH completely changed their life. Meanwhile, that same person on a peptide says, "I didn't really feel anything."
So why does this happen? Let me walk through it.
Age-Related Decline in GH Secretion
As we age, the pituitary gland loses sensitivity to growth hormone releasing hormones and peptides. So even when you take Ipamorelin, the pituitary just doesn't respond like it used to.
Older adults also have changes in sleep patterns. Reduced deep sleep means less natural GH release, since deep sleep is the main window for growth hormone secretion. If a 65-year-old isn't sleeping deeply, the peptide has nothing to work with.
There's also more somatostatin with age. Somatostatin inhibits GH release. So you're fighting an uphill battle on multiple fronts.
Exercise response also drops. Physical activity normally stimulates GH release, but that responsiveness diminishes with age too.
The IGF-1 Conversion Problem
Here's what really matters. The pituitary makes growth hormone, then the liver converts it into IGF-1. IGF-1 is what actually gives you fat loss, muscle building, and anti-aging benefits.
It's like food. The question isn't how much you eat, but how much you digest and absorb. Same with GH. The question is how much converts to IGF-1.
Liver function declines with age. Protein synthesis efficiency drops. Older adults often don't eat enough protein to begin with. All of this limits IGF-1 production even when GH is present.
Chronic inflammation also blocks IGF-1 production and function. A 65-year-old has accumulated decades of oxidative stress and chronic disease that a 35-year-old hasn't.
Receptor Sensitivity Drops Too
Even if you make GH and convert it to IGF-1, the receptors have to work. With age, receptors get downregulated. Cellular aging changes their structure and function. Gene expression shifts. Cell membrane fluidity decreases.
There's also more circulating binding protein in older adults, which reduces how much GH and IGF-1 is actually free to bind to receptors.
The Hormonal Environment Matters
This is the piece most people miss. Testosterone and growth hormone work together. One plus one equals three.
Estrogen is necessary for converting GH into IGF-1. Most postmenopausal women have very low estrogen, which crushes that conversion. They also have low testosterone, another key precursor.
So picture this. A 65-year-old woman, no hormone replacement, takes Ipamorelin. Her pituitary is sluggish, her liver conversion is impaired, her estrogen is gone, her testosterone is low. Of course she doesn't feel anything.
Cortisol changes, thyroid variability, and insulin resistance all stack on top of this and further blunt GH action.
Increased Body Fat Makes It Worse
Adipose tissue is an endocrine organ. The more fat someone carries, the harder it is for GH to do its job.
Higher fat mass leads to leptin resistance, which affects GH dynamics. Fat tissue secretes pro-inflammatory cytokines that block GH signaling. Visceral fat in particular disrupts GH secretion through metabolic and hormonal interference.
Older people generally carry more body fat, especially visceral fat, which compounds every other problem on this list.
Why Bioidentical HGH Wins After 50
Bioidentical HGH gives the body the exact hormone it's deficient in. No conversion needed. No need to coax a tired pituitary into doing more work.
You get consistent, predictable blood levels you can actually monitor. You can dose precisely. You bypass somatostatin and the body's regulatory brakes.
You don't depend on endogenous production at all. So if the pituitary is mostly checked out, which is common in someone 65 or 70, it doesn't matter. The hormone is already there.
The response is faster. Metabolic effects, protein synthesis, bone density, all improve more reliably. Monitoring is simpler because there are fewer variables.
You also avoid peptide antibody buildup and pituitary desensitization, which I've talked about a lot. HGH is bioidentical, so the body doesn't see it as foreign.
My take
After about age 50 or 55, almost everyone is going to benefit more from bioidentical growth hormone than from a peptide. The bottleneck isn't making more GH. The bottleneck is converting it into IGF-1 and getting the receptors to listen. Peptides only solve the first problem, and they don't even solve that one well in older bodies.
I'm not saying peptides can't work in older adults. They can. But the odds drop the older you get. This is why the celebrities and the people who don't want you to know what they're doing are using HGH. It's the nectar of the gods for a reason. You can also stack HGH with peptides, which I get into more in the private community.
Experiment for yourself, but go in with realistic expectations based on your age and your hormonal baseline.
Full transcript click any paragraph to jump video
Hey, right. This is Hunter Williams. I hope you were doing amazing wherever you are at in the world. Today's video is going to be about human growth hormone versus peptides in aging individuals. So it's probably been about two years now. Seem to not be responding as well to growth hormone peptides supposed to human growth form on itself And it kind of got me thinking and Jay and I talked this talked a lot about this of why? Someone over the age of 50 would get better results from growth Hormone itself versus peptide so now I know the easy answer is growth hormones are superior
to Growth hormone Peptides, but it seemed like people in their 30s and 40s would Get as good or better Results from peptids and they would from Growth Horman itself But after the age of 50, you know, obviously depending on the person, I noticed that they would tend to get better results with growth hormone itself. And the results would be like, wow, it would such a game changer. Whereas like people under 35 and they're like yeah, growth hormones amazing, but someone that's like 65 like wow growth won't absolutely completely transform my life. So we were kind of thinking about it. wondered, you know, like after the age of 50, growth hormone production and IGF production is so low.
Would peptides really do anything? So today is hopefully a helpful video, but it's kind of my thought experiment and exploration into why older individuals, meaning over the ages of fifty, would respond to growth hormones exogenously better than growth-hormone peptide. So today, what I'm going to be laying out is my thesis and the reasons why I think so. And again, this isn't hard and fast science. It's just my own anecdotal report from my personal experience and experience of the thousands of people I have coached and helped and mentored and everything.
Uh, today what I'm gonna do is just explain and expand upon why I think for someone that's aging, you know, probably over the age of 50 or 55 is going to get much better and superior results, uh, as far as fat loss, anti-aging skin, muscle building, all the benefits that we use growth hormone for, um, from bio-identical human growth hormones as opposed to growth-hormone peptides, which basically just increase the body's natural growth production. So, we'll see how this video does. It's something that, ah, we've been asked a lot about, and I'm passionate about just learning and kind of exploring.
So today is my best summation and thesis and treatise on this specific topic. That being said, if you want the peptide cheat sheet, don't forget to check out The link down in the description that will sign you up for the peptide cheat sheet and you'll sign up on my email list And then thank you to everyone that has been coming to the channel at least growing like crazy Which is amazing and just know that I do see all the comments and everything and I work to address those to my Q&A Videos that are published to The channel and on the podcast and also forget to mention I don't ever talk about this in videos but check out the podcasts if you listen on The road or you know,
just like I while you're exercising or something like that, I do have my videos as audio versions in the podcast and most of everything I talk about on the video can be listened to as an audio format. So check out iTunes, Spotify, all that good stuff for that. Without further ado, let's hop on to the screen and let us find out why human growth hormone works better in aging individuals than similarly peptides do. All right. So let's find out what the differences in HGH versus peptides in aging individuals and why, as we age, we can probably vary in our response to those.
Basically, just to set the context here, HTH equals exogenous hormone for the body to use. Human growth hormone, when we're talking about HCH use, is going to be the synthetic recombinant human growth that you can get from a pharmaceutical provider to inject and use it yourself. And it's typically used in growth hormone deficiency, whereas peptides increase the body's natural growth, hormone production. So the question that I set out to answer through my years of doing this is why do younger people respond to peptide for growth hormones better than older people?
And today we're going to hopefully come up with an answer for that question. So basically, let's look at age related growth hormone secretion decline. So natural age-related decline in growth, hormone production decreases the overall hormonal baseline affecting the pituitary glands capacity to produce and secrete GH. Basically what happens is as we age, as with most of the hormones in our body, the particular gland isn't able to produced GH as well. What happens? The pituitary gland sensitivity to growth hormone releasing hormones and peptides like Ipamerelin decreases with age.
So this is what's going on. As our pitutary glands ages with our body, the sensitivity two peptide actually decreases. Hence why someone that's 35 is going to respond better to Ippamerelin or Tessameralin than someone who is 65. Also, what happens is older adults often experience changes in sleep patterns, which is, you know, very common to see such as reduced deep sleep, Which is a crucial time for growth hormone release, further limiting GH secretion. So if a person is 65 and they use Ipameralin, The question is, is the person going to sleep deep enough to even allow for the pituitary gland to secrete
the new amount of growth hormone that the iparelin is supposed to help produce? Then this leads into regulatory feedback. So increased somatostatin, which is a growth-hormone inhibitory hormone, with aging can further suppress the pituitary's ability to release growth hormone. So as we age, we have an increase in somatostatin, which can, further, suppress our ability, to, release, growth from a pitutary gland. And then we, have reduced exercise response. Physical activity stimulates growth, hormone release. But the responsiveness can diminish with age.
which reduces the efficacy of natural and peptide-stimulated GH release. So we can see where this is going and hopefully this makes sense. The next part of this, is IGF production. Basically, long story short, the pituitary gland produces growth hormone and then that growth hormones in the liver gets converted into IGf, which is what will give us the benefits of fat loss, muscle building, anti-aging, all that. stuff. So let's look at liver function. so decline in liver functioning with age can impair the liver's ability to produce IGF-1 in response to growth hormone.
Again, it's kind of like, It's not about what you eat, about you digest and absorb. It is kind similar with growth hormones. it is not how much growth we have, but how many gets digested into IG-F1. Decreased efficiency in protein synthesis and odor of individuals can lead to reduced IGF-1 levels despite adequate GH levels. So if we're increasing growth hormone naturally through a peptide, that's going to raise our GH. But is the liver converting that GH into the IG-F1 that we can then use and then manifest in the benefits of the body?
Also, Inadequate nutrition commonly found in elderly populations because a lot of older people don't get enough protein can limit the substrates necessary for effective IGF-1 production in the liver. There's also the idea of inflammation in body. So typically, generally speaking, someone that's 35 is going to have less inflammation than someone 65 just because the person that 65 has accrued a chronic disease and inflammation through living longer on the planet. They've been exposed to more oxidative stress. So elevated levels of chronic inflammation and aging can inhibit IGF-1 production and function.
And we also have the hormonal interference, so changes in other hormone levels like estrogen and testosterone, as we know, decline with age. These can negatively impact IG-F1 synthesis and action, which again goes back to why do we look at total hormone optimization. Because if you have requisite and elevated and optimized levels of testosterone in the body, it's one of the amazing many benefits is going to help IGF-1 synthesis from growth hormone, be that through a peptide, you know, in a liver. So a lot of people will be 65. They're not using testosterone therapy or they're now using hormone therapy.
If they are a woman, And then they take it from Rellon. Maybe it works, maybe it doesn't. I've heard a lot of people say, I didn't even feel anything from it. Well, they don't have testosterone in their body, which is one of the key precursors to help deliver, convert growth hormone into IGF-1, Which is then going to, you know, confer the benefits that we're looking for. So let's look at the changes in the growth, hormone and IG-F1 receptor sensitivity. First of all, receptor downregulation. Chronic exposure to altered levels of GH and IJF one can lead to down regulation of receptors, making tissue less responsive.
So, then that leads us to cellular aging. So cellular agent can result in changes to receptor structure and function, reducing their effectiveness, effectiveness and signal transduction. so basically, as we age, the receptor, structure, and functioning is not going to be. functioning as efficiently as it would if we were younger so that we also have the genetic expression to age related changes, and gene expression can affect the number and efficacy of gh and IGF one receptors at the cellular level. And we of cell membranes with age can affect receptor mobility and function.
Obviously, it tends to decline with the age. And then we have competitive binding. So this is obviously getting pretty esoteric, but increased circulating levels of binding proteins in older adults can reduce the availability of GH and IGF1 for receptor interaction. As we age, increase in binding protein, which then doesn't allow the GH or IGf1 to interact with cell at the receptor level. Also, we've got the hormonal environment. So I hinted at a little bit of this, but let's kind of dive into this more at deeper level.
As I say, testosterone plus growth hormone, one plus one equals three. The benefits together outweigh the benefits in isolation. But when we look at testosterone decline, obviously that's happening in the population en masse right now, and also in older people, they just tend to have lower levels of testosterone. Decreased testosterone levels can diminish the synergistic effects it has with GH on muscle and strength building. Also, when we look at estrogen changes, alterations in estrogen can impact GH secretion and IGF-1 levels, especially in postmenopausal women. This is one of those things no one really understands or talks about, and I'm not claiming to be a master, but estrogen is necessary for the conversion
of growth hormone into IG-F1. So you pull estrogen from the body, as in most older women after menopause, because they have low testosterone. uh you know again it doesn't matter you could have all the growth hormone level in the world but if it's not getting converted it didn't. Then we have adrenal hormones so changes in cortisol and adrenal function with age can antagonize gh effects and promote catabolic states then we. Have the thyroid so variability in thyroid hormone levels can impact overall metabolism which affects how the body utilizes gh then. We have insulin resistance so increases in insulin.
Resistance with. Age can impair growth hormone signaling and function due to the metabolic interplay between insulin and GH. So you can see all of these cascade of hormones that are down, you know, decreasing in the body with age are going to be what's a factor in preventing that new found growth home on assuming it is. increased from the peptide of converting an IGF-1 and again, conferring the benefits where, as if we use growth hormone itself, it's kind of bypassing that to allow for the body to respond better.
So let's look at increased adiposity, which just means fat. Adipose tissue as an endocrine organ. Increased adposed tissue acts as endocrine organ, secreting factors that can negatively influence GH secretion and action, meaning that the fatter you are, the harder it is for GH to do its job, in most cases, like someone is probably going to have more fat on their body if they're older than if you're younger. Not always, but... We also have leptin resistance, so higher fat mass leads to increased lepton in the body, which may cause lepton resistance which affects growth hormone dynamics.
We have inflammatory cytokines, adipose tissue or fat secretes pro-inflammatory cytocines that can inhibit growth hormones signaling pathways. And then we've got the IGF-1 factor binding proteins, or excuse me, IGIF binding protein. So adepose tissues can alter levels of IGFI binding, proteins which affect the bioavailability of IgF1. And then we have the visceral fat accumulation. So increased visceral fat particularly affects GH accretion negatively due to specific metabolic and hormonal disruptions associated with central adiposity
of fat. So this leads us to HGH versus peptide. So let's look at it. Bioidentical HCH provides the exact hormone that is deficient, making it immediately available for the body to use without the need for conversion or activation processes. Again, we're kind of bypassing this mechanism of having the pituitary have to stimulate more and then increase that into IGF. When we're looking at HGH, it also allows for consistent and predictable blood levels of growth hormone, which can be more efficiently monitored and adjusted
compared to peptides that indirectly stimulate GH production, whereas we don't really know how much is being increased. Is it 10%, 1,000%? It's hard to say without blood work, but then even then the blood can get tricky. And then there's the reduced dependency on endogenous production. So unlike peptides rely on the body's ability to produce growth hormone, bioidentical HGH works independently of the individual's natural GH secretion, which is beneficial in cases where the pituitary gland is significantly impaired as we have seen is probably likely with age.
And then we've got precision dosing. So with exogenous GH, we can precisely control hormone dosage with bioidentical HGH and is crucial for older adults who may be sensitive or have varying needs. And also too, you can bypass these regulatory feedback loops. Direct HTH administration bypasses the body's natural regulatory mechanisms, such as somatostatin, which inhibits GH release, potentially providing more effective treatment outcomes. Also, we've got the effectiveness for severe deficiency.
So if someone gets in their sixties and seventies, probably have very little, you know, if any growth hormone on the body. In cases of severe deficiencies, bioidentical HGH can be more effective because it does not rely on a body's compromised capacity to produce GH. There's also much more of a rapid response, as opposed to peptides. So patients experience improvements in symptoms and physiological function more quickly due to the direct supplement of growth hormone. Then we've got improved metabolic effects. Direct administration of HGH can more effectively improve metabolism, which includes a better lipid profile, i.e.
our cholesterol and carbohydrate metabolism. which are often of areas concerned in older individuals. Then we have enhanced protein synthesis. So bioidentical HEH directly promotes protein syntheses, which is crucial for muscle maintenance and repair, an important aspect for aging individuals, then we had bone density improvements. It has been shown to improve bone-density more effectively than peptides, Which is particularly important for the prevention of osteoporosis in the older adults. Then there's the ease of monitoring. So the effects of bioidentical HGH can be straightforward to monitor through blood tests, simplifying the management of therapy.
We also have fewer variables to consider because we're not depending on the body's hormonal cascades, varying testosterone levels and all those things. And then we have you know, the avoidance of overstimulating the pituitary gland. So direct HEH does not risk overstimmulating in the patient's pituatory gland, which can be a concern with some peptides. And then we also don't have the, it's much of a risk of developing resistance. Um, so continuous use of peptide can potentially lead to desensitization of the pituatory to peptidized stimuli.
Like I talk about all the time with pepti immune response and peptided antibody buildup. Uh, and then, we avoid this because HE is bioidentical. It's not seen as a foreign substance to the body. Um, so that is it for the slides. So I would just sum up by saying that, uh, I know that was kind of a esoteric and more complex discussion, but when we look at, you know, older individual growth hormone versus peptides, what's going to be better for them? I think in almost all cases after the age of 50 or 55, someone's gonna benefit vastly more from bioidentical growth hormones because again,
it's the conversion into IGF. That is more of the issue as opposed to just raising growth in the body. And again, if we are telling the pituitary gland to raise growth hormone, but it can't effectively do that because in an older individual, the function is just not there, then what is the point of trying to use a peptide to do it? So I'm not saying that peptides can work, But I think as you age, there is definitely a lower and lower chance that you're going to get the benefit of a growth-hormone peptid versus growth hormones itself.
So again this is why all the celebrities and all of the people they don't want you to know about are using growth It is quote unquote the nectar of the gods but experiment for yourself so I think you can use both of them in conjunction as well I've talked to talked a good bit about that more so in the private community we have about how to use growth hormone with peptides to maximize the benefit of use of growth hormone itself. So hopefully that was helpful to you guys.
Again, I know a little bit more of a complex discussion, but I wanted to answer this because I get this question all the time, like, Hey, 62. And I used, uh, if a Maryland, it didn't really do anything for me. That's all for this one. Hopefully it was helpful. If you have questions, comments, concerns, definitely drop those below. Again, I'm doing my best to take those, summarize them and then answer all the comments in the Q&A video that I publish periodically. So thank you guys so much. Much love out there.
Don't forget to check out the links, you know, sign up for the email list on the description and I'll talk to you in next one, peace.
